EverPoint Asset Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

EverPoint Asset Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-150,000	Closed	-$1.88M	–	567
2016 Q2	$1.88M	Sell	150,000 -154,593	-51%	-$1.44M	0.04%	326
2016 Q1	$2.49M	Sell	304,593 -57,661	-16%	-$435K	0.05%	318
2015 Q4	$3.64M	Buy	362,254 +22,254	+7%	+$231K	0.08%	299
2015 Q3	$3.28M	Buy	+340,000	New	+$4.77M	0.09%	274

Other funds holding TBRA

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

EverPoint Asset Management's TBRA Position: Q3 2016 in Review

EverPoint Asset Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2016, closing a stake of 150,000 shares — an estimated $1.88M sold.

EverPoint Asset Management first reported a position in TBRA in Q3 2015 and held it in 4 quarters. The position peaked at $3.64M in Q4 2015. 68 funds tracked by Wall St. Rank hold TBRA as of Q3 2016.

EverPoint Asset Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
EverPoint Asset Management sold 150,000 Tobira Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $1.88M.
EverPoint Asset Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
EverPoint Asset Management's Tobira Therapeutics, Inc. Common Stock position peaked at $3.64M in Q4 2015.
68 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2016.

Based on EverPoint Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.